BIN1 knockdown rescues systolic dysfunction in aging male mouse hearts.
Maartje WesthoffSilvia G Del VillarTaylor L VoelkerPhung N ThaiHeather C SpoonerAlexandre D CostaPadmini SirishNipavan ChiamvimonvatEamonn James DicksonRose E DixonPublished in: Nature communications (2024)
Cardiac dysfunction is a hallmark of aging in humans and mice. Here we report that a two-week treatment to restore youthful Bridging Integrator 1 (BIN1) levels in the hearts of 24-month-old mice rejuvenates cardiac function and substantially reverses the aging phenotype. Our data indicate that age-associated overexpression of BIN1 occurs alongside dysregulated endosomal recycling and disrupted trafficking of cardiac Ca V 1.2 and type 2 ryanodine receptors. These deficiencies affect channel function at rest and their upregulation during acute stress. In vivo echocardiography reveals reduced systolic function in old mice. BIN1 knockdown using an adeno-associated virus serotype 9 packaged shRNA-mBIN1 restores the nanoscale distribution and clustering plasticity of ryanodine receptors and recovers Ca 2+ transient amplitudes and cardiac systolic function toward youthful levels. Enhanced systolic function correlates with increased phosphorylation of the myofilament protein cardiac myosin binding protein-C. These results reveal BIN1 knockdown as a novel therapeutic strategy to rejuvenate the aging myocardium.
Keyphrases
- left ventricular
- blood pressure
- heart failure
- binding protein
- oxidative stress
- cell proliferation
- high fat diet induced
- clinical trial
- liver failure
- gene expression
- type diabetes
- poor prognosis
- machine learning
- pulmonary hypertension
- intensive care unit
- dna methylation
- insulin resistance
- escherichia coli
- acute respiratory distress syndrome
- respiratory failure
- atrial fibrillation
- dengue virus
- rna seq
- high resolution
- drug induced
- stress induced
- skeletal muscle
- mechanical ventilation